<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe acquired aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> is associated with high morbidity and mortality despite improvement in the results obtained both with bone marrow transplantation and with immunosuppressive treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Early bone marrow transplantation is the treatment of choice for patients under 45 years of age, if the neutrophil granulocyte count is less than 0.2-0.5 x 10(9)/l and an HLA-identical sibling donor is available </plain></SENT>
<SENT sid="2" pm="."><plain>Other patients should receive primary immunosuppression with antithymocyte globulin, cyclosporin and <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> in combination with granulocyte colony-stimulating factor </plain></SENT>
<SENT sid="3" pm="."><plain>If they fail to respond after three months, and a donor is available, such patients may be treated with bone marrow transplantation </plain></SENT>
<SENT sid="4" pm="."><plain>However, transplantation with marrow from donors other than HLA-identical siblings is still at an experimental stage </plain></SENT>
</text></document>